Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000493791 | SCV000582880 | pathogenic | not provided | 2020-07-06 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 21683322, 27245183) |
Centre for Mendelian Genomics, |
RCV000626616 | SCV000747317 | pathogenic | Metaphyseal chondrodysplasia | 2017-01-01 | criteria provided, single submitter | clinical testing | |
Centre for Mendelian Genomics, |
RCV000626617 | SCV000747318 | likely pathogenic | Short stature; Wide mouth; Wide nasal bridge; Relative macrocephaly | 2017-01-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000779168 | SCV000915687 | likely pathogenic | Geleophysic dysplasia | 2017-04-27 | criteria provided, single submitter | clinical testing | The FBN1 c.5183C>T (p.Ala1728Val) missense variant has been reported in two studies and found in a total of four individuals from three unrelated families affected with FBN1-related disorders, including acromicric dysplasia and geleophysic dysplasia, all in a heterozygous state (Le Goff et al. 2011; de Bruin et al. 2016). The individual reported in Le Goff et al. (2011) study was de novo for the variant, while one patient reported in de Bruin et al. (2016) study inherited the variant from affected mother. The variant was absent from the 1000 Genomes Project, Exome Sequencing Project, the Exome Aggregation Consortium and the Genome Aggregation Database in a region of good sequence coverage so the variant is presumed to be rare. Based on the evidence, the p.Ala1728Val is classified as likely pathogenic for FBN1-related disorders. This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. |
Invitae | RCV001387308 | SCV001587905 | pathogenic | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2023-10-08 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1728 of the FBN1 protein (p.Ala1728Val). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of acromicric dysplasia or geleophysic dysplasia (PMID: 21683322, 27245183). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 430150). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FBN1 protein function. This variant disrupts the p.Ala1728 amino acid residue in FBN1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 21683322). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Genome Diagnostics Laboratory, |
RCV002279270 | SCV002566535 | likely pathogenic | Connective tissue disorder | 2022-06-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000493791 | SCV003917382 | pathogenic | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | FBN1: PM2, PM6, PS4:Moderate, PP1, PP2, PP3, PP4 |
Beijing Key Laboratory for Genetic Research of Skeletal Deformity, |
RCV001293674 | SCV001482391 | likely pathogenic | Geleophysic dysplasia 2 | 2019-05-31 | no assertion criteria provided | research | |
Department of Pediatrics, |
RCV004556061 | SCV005045298 | likely pathogenic | Acromicric dysplasia | 2024-02-01 | no assertion criteria provided | clinical testing |